Key pathways implicated in the pathogenesis of canine lymphoma include the nuclear factor kappa B (NF-κB) pathway, which is often activated in B-cell lymphomas, and the mechanistic target of rapamycin (mTOR) pathway, which is frequently altered in T-cell lymphomas [40,41,42]. Here, MTOR is linked to T-cell non-Hodgkin lymphoma.